It further demonstrated that functional characteristics of CD39+CD103+ CD8+ T cells (which harbor high cytotoxicity and potential to kill autologous cancer cells in vitro) have a significant biological relevance in the tumor nest in situ which ultimately affects patient outcome in a cohort of early untreated NSCLC patients. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.